Nutritional, Metabolic, Endocrine Diabetes T2
Conditions
Interventions
groups of diabetic treatments like, metformin
groups of diabetic treatments like,sulphonylureas,
groups of diabetic
groups of diabetic treatments ,insulin
Sponsors
none
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 50 T2D-free controls and 100 patients diagnosed with type 2 diabetes and on any of the oral hypoglycemic agents will be recruited.T2D-free controls enrolled in the study had no type I or II diabetes.
Exclusion criteria
Exclusion criteria: Patients with infectious diseases, autoimmune disorders, asthma, eczema, allergies, thyroid diseases, kidney failure, liver dysfunction and alcohol abuse will be excluded from the study. In addition, patients who underwent medication changes during the 2 months preceding participation will be also excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The association between IL-17,IL-18, IL-23,IL-10,IL-37 and IL-35 production and glycemic control of T2D in Egyptian patients were elucidated. | — |
Secondary
| Measure | Time frame |
|---|---|
| the association between diabetic clinical complications of T2D and inflammatory cytokines were observed | — |
Countries
Egypt
Contacts
Public ContactMohamed Zanaty
Biotechnology Department, Postgraduate Studies for Advanced Science, Beni-Suef University, Egypt
Outcome results
None listed